Geode Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
Geode Capital Management's NBP Position: Q3 2026 in Review
Geode Capital Management reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 36% in Q3 2026, selling an estimated $43.4K and leaving 44,124 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4165.
Geode Capital Management first reported a position in NBP in Q3 2020 and has held it in 25 quarters since. The position peaked at $11.6M in Q2 2021. 15 funds tracked by Wall St. Rank hold NBP as of Q3 2026.
- Geode Capital Management held 44,124 shares of NovaBridge Biosciences American Depositary Shares worth $60.2K as of Q3 2026.
- Geode Capital Management sold 24,725 NovaBridge Biosciences American Depositary Shares shares in Q3 2026, an estimated $43.4K.
- NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4165 holding.
- Geode Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 25 quarters since.
- Geode Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $11.6M in Q2 2021.
- 15 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.